ENTPD2 and neoplasm: The medium intercalated between tumor and ATP-WCBs in the sealed DSC was CFEM (to favor HC opening), supplemented with ARL 67156, an ecto-ATPase inhibitor [34], used to prevent rapid ATP degradation (EGTA was omitted because it interfered with ATP-WCBs activity).